PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.70%
Negative net income growth while MRVL stands at 6.10%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
5.08%
Some D&A expansion while MRVL is negative at -7.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-171.15%
Negative yoy deferred tax while MRVL stands at 22.22%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
18.18%
SBC growth while MRVL is negative at -8.15%. John Neff would see competitor possibly controlling share issuance more tightly.
-214.16%
Both reduce yoy usage, with MRVL at -152.26%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-146.86%
Both yoy AR lines negative, with MRVL at -190.07%. Martin Whitman would suspect an overall sector lean approach or softer demand.
440.00%
Some inventory rise while MRVL is negative at -127.39%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-1000.00%
Negative yoy AP while MRVL is 921.39%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-1161.54%
Negative yoy usage while MRVL is 76.99%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
117.19%
Well above MRVL's 163.64%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-61.47%
Both yoy CFO lines are negative, with MRVL at -59.01%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
28.04%
CapEx growth well above MRVL's 40.25%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with MRVL at -110.49%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-43.97%
Negative yoy purchasing while MRVL stands at 10.16%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
14.60%
We have some liquidation growth while MRVL is negative at -35.17%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
148.72%
Growth well above MRVL's 194.89%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-147.97%
Both yoy lines negative, with MRVL at -99.67%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
68.45%
Issuance growth of 68.45% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
1.91%
Buyback growth below 50% of MRVL's 16.80%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.